Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07963.x/fullpdf
Reference10 articles.
1. The evolution of thalidomide and its IMiD derivatives as anticancer agents;Bartlett;Nature reviews. Cancer,2004
2. Salvage regimens for Hodgkin lymphoma;Cashen;Clinical Advances in Hematology & Oncology,2008
3. Lenalidomide for the treatment of B-cell malignancies;Chanan-Khan;Journal of Clinical Oncology,2008
4. Report of an international workshop to standardize response criteria for non-Hodgkinâs lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999
5. The potential role of innate immunity in the pathogenesis of Hodgkinâs lymphoma;Enblad;Hematology/Oncology Clinics of North America,2007
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma;Haematologica;2023-09-14
2. EVOLUTION OF DRUG THERAPY FOR CLASSICAL HODGKIN LYMPHOMA;South Russian Journal of Cancer;2022-08-31
3. Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts;American Journal of Hematology;2021-07-29
4. Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis;British Journal of Haematology;2021-01-31
5. Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series;Therapeutic Advances in Hematology;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3